Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001390478-15-000050
Filing Date
2015-11-09
Accepted
2015-11-09 16:52:20
Documents
14
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gale-20150930x10q.htm 10-Q 1077087
2 EXHIBIT 10.6 gale20150930ex106.htm EX-10.6 114821
3 EXHIBIT 10.7 gale20150930ex107.htm EX-10.7 53756
4 EXHIBIT 31.1 gale20150930ex311.htm EX-31.1 8192
5 EXHIBIT 31.2 gale20150930ex312.htm EX-31.2 8284
6 EXHIBIT 32.1 gale20150930ex321.htm EX-32.1 6883
13 logo-vertical.jpg GRAPHIC 21485
14 pipelineimageq32015.jpg GRAPHIC 584704
  Complete submission text file 0001390478-15-000050.txt   7061609

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT gale-20150930.xml EX-101.INS 1208117
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gale-20150930.xsd EX-101.SCH 58207
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gale-20150930_cal.xml EX-101.CAL 71719
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gale-20150930_def.xml EX-101.DEF 252169
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gale-20150930_lab.xml EX-101.LAB 672025
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gale-20150930_pre.xml EX-101.PRE 390688
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 151216385
SIC: 2834 Pharmaceutical Preparations